LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
News-Medical.Net on MSN
Toddler thrives after receiving newly FDA-approved cochlear implant system
Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, ...
Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...
Cochlear Ltd (ASX:COH) presented its half-year 2026 results on February 13, revealing mixed financial performance that triggered a significant market reaction. The global hearing implant leader ...
Capital Brief on MSN
Cochlear sinks after Nexa rollout hits half-year profit
More news: Shares in Cochlear plunged in early trade after the company reported a 21% fall in statutory net profit. The rollout of its Nucleus Nexa system took longer than expected and weighed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results